Clinical and laboratory data of renal patients with and without CV events during follow-up
| CV Events(n = 10) | No CV Events(n = 167) | |
|---|---|---|
| Gender (male/female [%]) | 9/1 (90/10) | 109/58 (65/35) |
| Age (yr) | 53.5 ± 7.1 | 45.9 ± 12.3 |
| Body mass index (kg/m2) | 26.1 ± 1.6 | 25.1 ± 3.8 |
| Current smoker (n) | 1 (10%) | 33 (20%) |
| Past smoker (n) | 1 (10%) | 43 (19%) |
| Previous CV event | 2 (20%) | 20 (26%) |
| Serum creatinine (mg/dl) | 1.96 (1.39 to 2.88) | 1.70 (1.22 to 2.76) |
| GFR (ml/min per 1.73 m2) | 39 (32 to 60) | 57 (37 to 90) |
| Proteinuria (g/24 h per 1.73 m2) | 0.30 (0.09 to 2.19) | 0.72 (0.21 to 1.55) |
| High sensitivity C-reactive protein (mg/L) | 1.10 (0.90 to 1.51) | 1.70 (0.70 to 4.00) |
| Intact parathyroid hormone (pmol/L) | 7.1 (5.9 to 15.6) | 6.5 (3.9 to 15.3) |
| Systolic BP (mmHg) | 148 ± 24 | 136 ± 20 |
| Diastolic BP (mmHg) | 89 ± 13 | 86 ± 13 |
| Pulse pressure (mmHg) | 59 ± 22 | 50 ± 15a |
| Use of antihypertensive drugs (n) | 10 (100%) | 133 (80%) |
| Insulin (mU/L) | 14.1 ± 6.5 | 13.5 ± 9.9 |
| Glucose (mg/dl) | 110 ± 25 | 97 ± 15b |
| HOMA-IR | 4.02 ± 2.86 | 3.43 ± 3.56 |
| Adiponectin (μg/ml) | 3.0 ± 1.3 | 6.5 ± 4.5a |
| Total cholesterol (mg/dl) | 215 ± 33 | 216 ± 44 |
| LDL cholesterol (mg/dl) | 137 ± 29 | 138 ± 39 |
| Triglycerides (mg/dl) | 157 (106 to 286) | 144 (104 to 221) |